top of page
Search


Newborn screening for spinal muscular atrophy improves chances of walking and quality of life: study
Testing in the newborn period is more effective than conventional clinical diagnosis pathways for improving health outcomes in infants wit

Jonathan Shar
Jan 19, 20234 min read


Evrysdi (risdiplam) for the Treatment of Spinal Muscular Atrophy (SMA)Share
Evrysdi™ (risdiplam) is the first and only oral medication indicated for the treatment of spinal muscular atrophy (SMA) in patients of two m

Jonathan Shar
Aug 20, 20204 min read
bottom of page








